Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity by Machado, E. et al.
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 113(9): e180085, 2018 1|5
online | memorias.ioc.fiocruz.br
GENOME ANNOUNCEMENT AND HIGHLIGHT
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Mycobacterium kansasii is an opportunistic pathogen and one of the most commonly encountered species in in-
dividuals with lung disease. We here report the complete genome sequence of 12 clinical isolates of M. kansasii from 
patients with pulmonary disease in Brazil.
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Nontuberculous Mycobacterium (NTM) species are 
widespread in the (man-made) environment and some 
species cause opportunistic infections in humans. Myco-
bacterium kansasii, frequently isolated from tap water, is 
a slow-growing photochromogenic NTM and a pathogen 
that is commonly isolated from patients with pre-existing 
lung disease, similar to other NTM clinical species such 
as M. abscessus, M. avium complex, M. malmoense and 
M. xenopi.(1) In the USA and South America M. kansasii 
is the second most isolated NTM after M. avium com-
plex(2,3) while in Rio de Janeiro, it is the most frequent 
NTM to cause pulmonary disease.(4) Besides chronic 
bronchopulmonary disease, M. kansasii causes other 
clinical manifestations such as lymphadenitis(5), skin and 
soft tissue infection(6), tenosynovitis, arthritis, osteomy-
elitis and disseminated infection in patients co-infected 
with human immunodeficiency virus.(7)
Seven major genotypes (I to VII) of M. kansasii have 
been described and while human isolates are mainly of 
types I and II (with type II mainly HIV-related)(8,9), en-
vironmental isolates are mostly of the other subtypes.(10) 
Type I has been described as a heterogeneous group, in-
completely characterized on the genomic level.(11,12) Re-
cently, the genome sequence of the ATCC strain 12478 
Hauduroy isolated in Kansas in 1955 has been compared 
with that of the M. tuberculosis strain H37Rv(13), while 
other M. kansasii genomes are available from environ-
mental(14), human(15) and simian(16) sources.
Here, we report the genome sequence of 12 clinical M. 
kansasii isolates belonging to genotype I, as determined 
by hsp65 sequencing. The strains were isolated from hu-
man Brazilian patients with pulmonary disease and pos-
sibly earlier tuberculosis. Nine isolates were from sputum, 
two from bronchoalveolar lavage (7287 and 10742) and 
one of unknown origin (1580). Isolates were from resi-
dents of the state of Rio de Janeiro (n = 7), Pernambuco 
(n = 3), Rio Grande do Sul (n = 1), and Santa Catarina (n 
= 1). Genomic DNA libraries were constructed using the 
Nextera XT DNA library kit and whole-genome shotgun 
sequencing was performed on the Illumina HiSeq2500 
platform, generating paired end reads of 2 × 100 bp. Ge-
nomes were de novo assembled using SPAdes software 
version 3.11.1(17), and annotated with RAST(18) (Table). No 
evidence for the presence of plasmids was observed.
To evaluate the overall similarity of the genomes of 
the isolates from Brazil with that of the isolate ATCC 
12478, we also compared the 12 genomes with the 
ATCC reference genome using the BLAST Ring Image 
Generator (BRIG) program(19) (Fig. 1).
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We observed many deletions spread in the genomes 
that were either shared by all or part of the isolates. Three 
isolates (1580, 3657 and 4404) presented a region of dif-
ference of about 27 kb causing the loss of five helicases, 
a restriction endonuclease and two hypothetical proteins. 
We also observed multiple deletions shared by the iso-
lates 1580, 3657, 4404, 8835, 8837 and 8839 (Fig. 1).
In addition, a reference-based single-nucleotide poly-
morphism (SNP) calling was performed against the ge-
nome of the M. kansasii ATCC 12478 strain using both 
Snippy (version 3.2; https://github.com/tseemann/snippy) 
and the wgSNP module of BioNumerics v7.6 (Applied 
Maths, Sint-Martens-Latem, Belgium). Most isolates 
presented homogeneously distributed SNPs over the 
entire genome, except for isolates 6849 and 6498 which 
clearly presented regions of higher SNP frequency (data 
not shown). As demonstrated by a Neighbour-Joining 
phylogenetic tree based on 5,607,341 sites and 1000 boot-
strap replicates (Fig. 2), three groups were observed when 
compared to the genome of the ATCC strain, one pre-
senting less than 100 SNP (n = 4) (middle part), a second 
with either less than 5,000 SNPs (n = 1) and more than 
10,000 SNPs (n = 1) (lower part) and a third group with 
more than 10,000 SNPs (n = 6) (upper part). We observed 
an association between SNP-based grouping and phylog-
eny on basis of large deletions, that led us suggest that the 
third group has evolved from the common ancestor.
From two patients, we performed whole genome se-
quencing of two isolates each; the pair of isolates from a 
patient from Rio de Janeiro (10742 and 10953) had 0 SNPs 
difference; the second pair from a patient from Recife (8837 
and 8839) presented 277 mutations (data not shown).
Additionally, two isolates (6498 and 8835) presented 
a Minimal Inhibitory Concentration of > 1 µg/mL for ri-
fampicin in vitro and both presented a non-synonymous 
SNP, localized respectively at position 4267612 (C to G) 
and 4267613 (A to C), causing an amino acid change in 
codon 411 of rpoB of respectively Gln to Glu and of Gln 
to Pro. We as such confirm the scarce existing data on 
the association between resistance against rifampicin and 
presence of point mutations in M. kansasii rpoB gene. In-
deed, point mutations in rpoB gene are the main reason 
for resistance against rifampicin and this has been con-
firmed in several bacteria. Also, molecular determinants 
of drug resistance in M. kansasii has been recently sug-
gested by Bakuła et al.(20). Among the present isolates, we 
observed considerable differences of in vitro virulence in 
macrophages as measured by growth and induction of ne-
crosis and of cytokine production (data not shown).
In conclusion, these are preliminary data on the 
variability within the M. kansasii genotype 1 in Brazil 
and, even on the basis of this small sample number, we 
evidenced three genetic groups that are separated by the 
presence of large number of SNPs throughout the ge-
nome and by the pattern of large deletions. One grouping 
of strains from Rio de Janeiro is highly similar to the 
ATCC strain Hauduroy (< 100 SNPs) that was isolated 
more than 70 years ago in the US. A second group of hu-
man isolates from Rio de Janeiro and Pernambuco pre-
sented over 10,000 SNPs when compared to the ATCC 
strain. We also observed an association between geno-
types and geographic origin of isolates, separating those 
from the states of Rio de Janeiro, Pernambuco and Santa 
Catarina. Our observation of considerable differences of 
in vitro and in vivo virulence and their differences on the 
genome level is under investigation.
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TABLE
Genome features, predicted genes, and GenBank accession numbers of  
Mycobacterium kansasii strains isolated in Brazil from patients with pulmonary disease
Isolate Accession Location Type (hsp65) Reads Genome size (bp) Contigs Coverage (x) Genes
BR3657 PQOL00000000 RJ 1Bd 18,094,408 6,374,282 294 80.90 5,965t
BR6498ª PQOM00000000 RS 1A 9,038,224 6,225,838 317 37.37 5,804
BR7287 PQON00000000 RJ 1A 19,684,890 6,282,326 274 79.59 5,842
BR6884 PQOO00000000 RJ 1A 21,305,254 6,411,468 280 125.91 5,980
BR6849 PQOP00000000 SC 1A 16,399,304 6,464,047 265 78.89 6,023
BR10953b PQOQ00000000 RJ 1A 14,895,938 6,284,879 297 52.02 5,850
BR10742b PQOR00000000 RJ 1A 14,634,490 6,289,619 282 53.58 5,864
BR1580 PQOS00000000 RJ 1B 20,820,372 6,307,487 226 143.20 5,913
BR4404 PQOT00000000 RJ 1B 4,686,134 6,282,923 466 31.43 5,880
BR8835ª PQOU00000000 PE 1B 16,906,236 6,228,381 321 53.45 5,775
BR8837c PQOV00000000 PE 1B 13,311,444 6,213,268 247 75.41 5,773
BR8839c PQOW00000000 PE 1B 9,434,892 6,178,862 270 52.48 5,727
a: resistant to rifampicin; b and c are pairs of isolates obtained from a single patient each. Isolates were from patients residents of 
Rio Grande do Sul (RS), Rio de Janeiro (RJ), Santa Catarina (SC) and Pernambuco (PE); d: 1B differs from the hsp65 sequence 
1A of the ATCC 12478 strain by a SNP A to G at genome position 39635339 (GenBank KJ186611.1).
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Fig. 1: BLAST ring image of the 12 Brazilian genomes against the ATCC 12478 reference genome.
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Fig. 2: Neighbor-Joining SNP-based tree of the 12 Brazilian isolates and the ATCC 12478 reference genome.
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